Coronavirus Pandemic

Research

Nadine Benador, MD
She is active in clinical research. She participated in the national Chronic Kidney Disease in Children Study, and was the local investigator for two multicenter trials.
Dr. Benador's publications on PubMed

Caitlin Carter, MD
She is active in clinical research. She is conducting outcome studies in transitioning pediatric patients to adult care.

Elizabeth Ingulli, MD
She is active in clinical research.  She is conducting outcomes studies in pediatric renal transplantation. She is a recognized expert on immune aspects of renal transplant rejection and is frequently invited speaker in national meetings.

Robert Mak, MD, PhD
He is active in basic and translational research: (1) Pathophysiology of uremic cachexia.  Dr. Mak recently published a number of papers on the significance of cytokine signaling in the pathogenesis of uremic cachexia.  Pharmacologic blockade of the pegylated leptin receptor is an exciting novel therapeutic strategy for uremic cachexia.  This is recently published in Journal of the American Society of Nephrology, the top nephrology journal (impact factor 9.3).  (2) “Genetic regulation of weight and height in children with chronic kidney disease.”  Dr. Mak is the PI on a genome wide association study with above title within the Chronic Kidney Disease in Children (CKiD) cohort  Dr. Mak is a co-Principal Investigator for a NIH funded national CKiD study, which follows over 800 patients.  He chairs the progression committee. This study has gone extremely well and the investigator team has been renewed for another five years, from 2013 to 2018.
Dr. Mak's publications on PubMed

Lieuko Nguyen, MD
She is active in clinical research. She is working on a cell phone based program to monitor compliance in patients with chronic kidney disease.

Noureddin Nourbakhsh, DO
He is active in clinical and translational research into acute kidney injury.

Elliot Perens, MD, PhD
He is interested and active in basic research in developmental nephrology. He obtained fellowship research support from the California Institute of Regenerative Medicine (CIRM) fellowship for 2012-2013 and a grant from the A.P. Giannini Foundation in 2015.

Peter Yorgin, MD
He is active in clinical research.  He is conducting outcomes studies in pediatric dialysis and lupus nephritis.  He is a recognized expert on anemia in chronic kidney disease and is frequently an invited speaker in national meetings.